Please login to the form below

Not currently logged in
Email:
Password:

guselkumab

This page shows the latest guselkumab news and features for those working in and with pharma, biotech and healthcare.

AbbVie lauds head-to-head win for Skyrizi versus Cosentyx

AbbVie lauds head-to-head win for Skyrizi versus Cosentyx

On paper Skyrizi is actually a closer competitor to Johnson &Johnson's Tremfya (guselkumab), which also targets IL-23, but there’s little doubt that – sales-wise at least – Cosentyx is

Latest news

More from news
Approximately 2 fully matching, plus 35 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics